13F-HR/A filed by PURA VIDA INVESTMENTS, LLC
PURA VIDA INVESTMENTS, LLC filed this 13F-HR/A for the quarter ended 2018-03-31, filed 2021-02-11, with 66 holding rows worth $169,275,000.
- Accession
- 0001493152-21-003348
- Filer
- CIK 1590144
- Filed
- 2021-02-11
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2018
A holdings report, amendment of type restatement, 66 entries on the cover page, a total value of $169,275,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $169,275,000 with VALUE read as thousands by filing date, 13F file number 028-16667. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Health Care Select Sector SPDR Fund | 81369Y209 | SHS | 160,000 | $13,024,000 | thousands by filing date | put |
| Merck & Co.,Inc. | 58933Y105 | COM | 200,000 | $10,894,000 | thousands by filing date | call |
| ICU MED INC | 44930G107 | COM | 28,000 | $7,067,000 | thousands by filing date | |
| GLOBUS MED INC CL A | 379577208 | Stock | 135,000 | $6,726,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 72,100 | $6,381,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 100,000 | $6,325,000 | thousands by filing date | call |
| CIGNA CORPORATION | 125509109 | COM | 35,000 | $5,871,000 | thousands by filing date | call |
| Merck & Co.,Inc. | 58933Y105 | COM | 100,000 | $5,447,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 45,000 | $5,016,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 75,000 | $4,878,000 | thousands by filing date | |
| SIENTRA INC | 82621J105 | COM | 503,600 | $4,865,000 | thousands by filing date | call |
| INVACARE CORP | 461203101 | COMMON STOCK | 276,796 | $4,816,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 110,000 | $4,323,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 50,000 | $4,167,000 | thousands by filing date | put |
| Abbott Laboratories | 002824100 | COM | 60,500 | $3,625,000 | thousands by filing date | |
| ATHENAHEALTH INC | 04685W103 | COMMON STOCK | 25,000 | $3,576,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 43,700 | $3,543,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 25,000 | $3,488,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 42,500 | $3,409,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 30,000 | $3,344,000 | thousands by filing date | put |
| SIENTRA INC | 82621J105 | COM | 294,172 | $2,842,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 37,140 | $2,754,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 422,000 | $2,713,000 | thousands by filing date | |
| QIAGEN NV | N72482123 | SHS NEW | 75,000 | $2,423,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 87,500 | $2,391,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 20,000 | $2,247,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 600,000 | $2,124,000 | thousands by filing date | put |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 584,563 | $2,069,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 50,268 | $2,013,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 50,000 | $1,975,000 | thousands by filing date | |
| NATUS MEDICAL INC | 639050103 | COM | 57,620 | $1,939,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 10,000 | $1,705,000 | thousands by filing date | call |
| ALLERGAN PLC | G0177J108 | SHS | 10,000 | $1,683,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 10,000 | $1,683,000 | thousands by filing date | put |
| INCYTE CORP COM | 45337C102 | Stock | 20,000 | $1,667,000 | thousands by filing date | call |
| SPECTRUM PHARMACEUTICALS INC | 84763A108 | COM | 100,000 | $1,609,000 | thousands by filing date | call |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 100,000 | $1,504,000 | thousands by filing date | |
| ACCURAY INC DEL | 004397105 | COM | 300,000 | $1,500,000 | thousands by filing date | call |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 67,000 | $1,469,000 | thousands by filing date | |
| NUVECTRA CORP | 67075N108 | COM | 112,500 | $1,465,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 71,459 | $1,340,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 15,000 | $1,250,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 40,000 | $1,233,000 | thousands by filing date | |
| CONFORMIS INC | 20717E101 | COM | 731,041 | $1,060,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 65,000 | $1,029,000 | thousands by filing date | |
| EVOLUS INC | 30052C107 | COM | 102,544 | $926,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 40,000 | $886,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 32,186 | $829,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 25,782 | $821,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 50,000 | $816,000 | thousands by filing date | call |
| ACER THERAPEUTICS INC | 00444P108 | CMN | 41,795 | $805,000 | thousands by filing date | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 174,870 | $764,000 | thousands by filing date | |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 67,610 | $725,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 50,000 | $710,000 | thousands by filing date | |
| STEADYMED LTD | M84920103 | SHS | 215,214 | $699,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 152,486 | $640,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 59,600 | $582,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 5,000 | $563,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 50,000 | $553,000 | thousands by filing date | call |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 20,000 | $515,000 | thousands by filing date | put |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 21,700 | $485,000 | thousands by filing date | |
| MOTUS GI HLDGS INC | 62014P108 | COM | 100,000 | $448,000 | thousands by filing date | |
| ACCURAY INC DEL | 004397105 | COM | 88,958 | $445,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 15,000 | $237,000 | thousands by filing date | put |
| VASCULAR BIOGENICS LTD | M96883109 | COM | 100,000 | $230,000 | thousands by filing date | put |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 24,100 | $124,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-18-006744 | superseded | 2018-05-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001493152-18-011457 | superseded | 2018-08-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001493152-21-003348 | this filing | 2021-02-11 | acceptance time not in the bulk data set |